Journal Mobile Options
Table of Contents
Vol. 129, No. 4, 2013
Issue release date: May 2013

A Case Report of Acute Myeloid Leukemia after Liver Transplantation

Liu M. · Liu J. · Liu L. · Yu L. · Shi B. · Ye L. · Zhang Y. · Chen H.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Acute myeloid leukemia (AML) is a rare complication observed after liver transplantation and only a handful of cases have been reported until now. We report a case of acute promyelocytic leukemia (APL) after liver transplantation in a 50-year-old man. The case presentation was postodontectomy bleeding with an associative abnormal coagulation test 85 months after liver transplantation. A routine blood test, bone marrow test, chromosome analysis and examination of PML/RARα chimeric gene confirmed the diagnosis of APL and disseminated intravascular coagulation (DIC). Induction chemotherapy with all-trans retinoic acid, arsenic trioxide and daunorubicin was given to this patient and complete remission was achieved. The patient was subjected to DA (daunorubicin combined with cytarabine) and MA (mitoxantrone combined with cytarabine) regimens after remission induction to consolidate the chemotherapy for two courses of treatment, and subsequently subjected to arsenous acid chemotherapy on a periodic basis. Twenty-two months into the follow-up, sustained bone marrow remission was observed with the adapted treatment regimen.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Penn I: Posttransplant maglinacies. Transplant Proc 1999;31:1260–1262.
  2. Penn I: Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1998;147–158.

    External Resources

  3. Jiang N, Li H, Wang GS, Zhang J, Zhang JF, Yi SH, Yang Y, Cai CJ, Lu MQ, Chen GH: Acute leukemia, a rare but fatal complication after liver transplantation. Leuk Res 2009;33:1349–1351.
  4. Camós M, Esteve J, Rimola A, Grande L, Rozman M, Colomer D, Villamor N, Costa D, Montserrat E: Increased incidence of acute myeloid leukemia after liver transplantation? Description of three new cases and review of the literature. Transplantation 2004;77:311–313.
  5. Zhang GS, Dai CW, Peng HL, Xu YX, Pei MF: Myelodysplastic syndrome with transformation to acute monocytic leukemia with FLT3-ITD mutation following orthotopic liver transplantation. Leuk Res 2006;30:908–910.
  6. Cho YU, Chi HS, Park CJ, Seo EJ, Lee JH, Lee JH, Lee SG: Two cases of post-liver transplant acute myeloid leukemia in Korean adults: review of bibliographies and comparison with post-renal transplant acute myeloid leukemia. Ann Hematol 2008;87:513–514.
  7. Dantal J, Soulillou JP: Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 2005;352:1371–1373.
  8. Végso G, Sebestyén A, Paku S, Barna G, Hajdu M, Tóth M, Járay J, Kopper L: Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas. Leuk Res 2007;31:1003–1008.
  9. Barozzi P, Riva G, Vallerini D, Bosco R, Quadrelli C, Zanetti E, Potenza L, Forghieri F, Torelli G, Luppi M: Indirect antitumor effects of mammalian target of rapamycin inhibitors against Kaposi sarcoma in transplant patients. Transplantation 2009;88:597–598.
  10. Floryk D, Thompson TC: Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int J Cancer 2008;123:2294–2302.
  11. Doti CA, Gondolesi GE, Sheiner PA, Emre S, Miller CM, Aledort LM: Leukemia after liver transplant. Transplantation 2001;72:1643–1646.
  12. Bodó I, Peters M, Radich JP, Hess J, Blinder M, Watson MS, Van Rheeden R, Natarajan S, Lowell JA, Brown R, DiPersio J, Adkins D: Donor-derived acute promyelocytic leukemia in a liver-transplant recipient. N Engl J Med 1999;341:807–813.
  13. Sato T, Kobayashi R, Iguchi A, Nakajima M, Koizumi S, Furukawa H, Todoh S, Kobayashi K: Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls. Leuk Lymphoma 2005;46:1057–1060.
  14. Thalhammer-Scherrer R, Wieselthaler G, Knoebl P, Schwarzinger I, Simonitsch I, Mitterbauer G, Berlakovich GA, Mannhalter C, Haas OA, Mayer G, Muehlbacher F, Wolner E, Klepetko W, Lechner K, Jaeger U: Post-transplant acute myeloid leukemia (PT-AML). Leukemia 1999;13:321–326.
  15. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O’Grady J: Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002;8:482–487.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00